Restoring the Efficacy of COVID Therapeutics
June 14, 2024
June 14, 2024
WASHINGTON, June 14 (TNSres) -- The U.S. Department of Energy's Los Alamos National Laboratory issued the following news on June 13, 2024:
* * *
Combining computational and experimental approaches helps researchers address the efficacy of antibodies
* * *
Researchers from Los Alamos National Laboratory are helping restore the efficacy of Evusheld, a therapeutic used to treat COVID infections. The results were published today in Nature.
* * *
Combining computational and experimental approaches helps researchers address the efficacy of antibodies
* * *
Researchers from Los Alamos National Laboratory are helping restore the efficacy of Evusheld, a therapeutic used to treat COVID infections. The results were published today in Nature.